Search Results - "Saïagh, Soraya"

Refine Results
  1. 1
  2. 2

    Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients by Bouchet-Delbos, Laurence, Even, Amandine, Varey, Emilie, Saïagh, Soraya, Bercegeay, Sylvain, Braudeau, Cécile, Dréno, Brigitte, Blancho, Gilles, Josien, Régis, Cuturi, Maria-Cristina, Moreau, Aurélie

    Published in Transplantation (01-04-2021)
    “…BACKGROUND:Kidney transplantation is the therapeutic of choice for patients suffering from kidney failure. Whilst immunosuppressive drugs can control graft…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy by Zuliani, Thomas, Saiagh, Soraya, Knol, Anne-Chantal, Esbelin, Julie, Dréno, Brigitte

    Published in PloS one (24-07-2013)
    “…Fetal skin heals rapidly without scar formation early in gestation, conferring to fetal skin cells a high and unique potential for tissue regeneration and scar…”
    Get full text
    Journal Article
  5. 5

    NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial by L'Orphelin, Jean-Matthieu, Lancien, Ugo, Nguyen, Jean-Michel, Coronilla, Francisco J.S., Saiagh, Soraya, Cassecuel, Julie, Boussemart, Lise, Dompmartin, Anne, Dréno, Brigitte

    Published in Acta oncologica (07-11-2024)
    “…I the proliferation of intra-tumour CD8+ T cells is directly correlated with the clinical response, making tumour-infiltrating lymphocytes (TILs) a treatment…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients by Dréno, Brigitte, Khammari, Amir, Fortun, Agnès, Vignard, Virginie, Saiagh, Soraya, Beauvais, Tiffany, Jouand, Nicolas, Bercegay, Sylvain, Simon, Sylvain, Lang, François, Labarrière, Nathalie

    Published in Cancer Immunology, Immunotherapy (01-10-2021)
    “…Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones by Khammari, Amir, Labarrière, Nathalie, Vignard, Virginie, Nguyen, Jean-Michel, Pandolfino, Marie-Christine, Knol, Anne C., Quéreux, Gaëlle, Saiagh, Soraya, Brocard, Anabelle, Jotereau, Francine, Dreno, Brigitte

    Published in Journal of investigative dermatology (01-12-2009)
    “…Immunotherapy by adoptive T-cell transfer aims at maximizing tumor antigen-specific T-cell responses. We treated 14 patients at the metastatic stage in a phase…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Tissue biomarkers in melanoma patients treated with TIL by Knol, Anne-Chantal, Nguyen, Jean-Michel, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Brocard, Anabelle, Peuvrel, Lucie, Saint-Jean, Mélanie, Saiagh, Soraya, Khammari, Amir, Dréno, Brigitte

    Published in PloS one (20-12-2012)
    “…While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on…”
    Get full text
    Journal Article
  16. 16

    Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product by Salot, Samuel, Laplace, Catherine, Saïagh, Soraya, Bercegeay, Sylvain, Tenaud, Isabelle, Cassidanius, Alain, Romagne, François, Dreno, Brigitte, Tiollier, Jérôme

    Published in Journal of immunological methods (30-09-2007)
    “…gamma9delta2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit” by Salot, Samuel, Bercegeay, Sylvain, Dreno, Brigitte, Saïagh, Soraya, Scaglione, Virginie, Bonnafous, Cécile, Sicard, Hélène

    Published in Journal of immunological methods (15-08-2009)
    “…Interest in γ9δ2 T cells has increased greatly in the past decade. While several protocols allowed the amplification of a large proportion of these cells in…”
    Get full text
    Journal Article
  19. 19

    Large scale expansion of γ9δ2 T lymphocytes: Innacell γδ™ cell therapy product by Salot, Samuel, Laplace, Catherine, Saïagh, Soraya, Bercegeay, Sylvain, Tenaud, Isabelle, Cassidanius, Alain, Romagne, François, Dreno, Brigitte, Tiollier, Jérôme

    Published in Journal of immunological methods (30-09-2007)
    “…γ9δ2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also secrete…”
    Get full text
    Journal Article
  20. 20